Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome

Table 2 Characteristics of patients with an initial Lynch syndrome management visit between January 1, 2017 and October 29, 2020

	n = 155
Age (yr), median (IQR)	46 (33-58)
Female sex	100 (65%)
Race
White	139 (90%)
Black	3 (2%)
Asian	7 (5%)
Other	2 (1%)
Unknown	4 (3%)
Hispanic ethnicity	2 (1%)
Ashkenazi Jewish ancestry	16 (10%)
Lynch syndrome gene
MLH1	29 (19%)
MSH2 or EPCAM	40 (26%)
MSH6	45 (29%)
PMS2	41 (26%)
Personal history of cancer	70 (45%)
Small intestinal	2 (1%)
Urinary tract	6 (4%)
Colorectal	30 (19%)
Family history of cancer	151 (97%)
Small intestinal	8 (5%)
Urinary tract	35 (23%)
Colorectal	113 (73%)
Type of insurance
Private insurance	134 (86%)
Medicare insurance	16 (10%)
Medicaid insurance	5 (3%)
Provider
Provider 1	121 (78%)
Provider 2	17 (11%)
Provider 3	17 (11%)